Dipexium Pharmaceuticals, Inc.

Quick facts

Phase 3 pipeline

• Topical pexiganan cream 0.8% · Infectious Disease / Dermatology
  Pexiganan is an antimicrobial peptide that disrupts bacterial cell membranes, killing a broad spectrum of bacteria including antibiotic-resistant strains.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Dipexium Pharmaceuticals, Inc. portfolio CI brief
• Dipexium Pharmaceuticals, Inc. pipeline updates RSS